Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 17/20 | 0.72 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.72 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21257380 | 0.93 | ADORA3 (0.62) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL24615156 | 0.90 | ADORA3 (0.70) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL25566446 | 0.89 | ADORA3 (0.71) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL21779333 | 0.86 | ADORA3 (0.80) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL20122057 | 0.86 | ADORA3 (0.80) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL19503462 | 0.86 | ADORA3 (0.80) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL20122056 | 0.86 | ADORA3 (0.80) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL21779297 | 0.86 | ADORA3 (0.80) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL29319516 | 0.86 | ADORA3 (0.68) | ADORA3ADORA2AABCG2KCNH2ADORA1 | |
| SCHEMBL29316785 | 0.86 | ADORA3 (0.68) | ADORA3ADORA2AABCG2KCNH2ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091791-A1 | METHODS OF TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2017185061-A1 | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | ASTROCYTE PHARMACEUTICALS, INC. (US) | 2017-10-26 | — | — | WO | disclosed |